Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial - Gullestad, L; Mortensen, S A; Eiskjær, H (Transplantation, 2010)
, et al.